LIANA BAGHUMYAN: Open Payments
NPI 1659859510 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 16 payments from 4 companies in 2025. Trend: 2023 $205 · 2024 $460 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $335 |
| Boston Scientific Corporation | 1 | $28 |
| Abbott Laboratories | 1 | $27 |
| Galderma Laboratories, L.P. | 1 | $19 |
Products named: EMBLAVEO, AVYCAZ, SpyGlass Discover, DALVANCE, PERCLOSE PROSTYLE, BOTOX, TEFLARO.
Industry payments across CA — which companies pay providers there.
